Illumina, Inc. (ILMN), a major developer of life science tools for large-scale genetic analysis, has launched MiSeq FGx Forensic Genomics System, the first fully approved next-generation (NGS) system ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Focused power on the MiSeq i100 System Access focused applications such as targeted resequencing, metagenomics, small genome sequencing, targeted gene expression profiling, and more. MiSeq i100 ...
Illumina, Inc. (NASDAQ:ILMN) today announced that HistoGenetics, the leader in high-resolution sequence-based human leukocyte antigen (HLA) testing services, has selected the MiSeq sequencing system ...
The two new benchtop instruments, MiSeq i100 and MiSeq i100 Plus Systems, will empower customers to unlock powerful insights through an affordable, comprehensive solution that is simple to understand ...
Illumina has announced three innovative workflow solutions to support its MiSeq personal sequencer system. Designed for an optimal user experience, these products deliver a sequencing ecosystem that ...
Caris Life Sciences has selected Illumina’s MiSeq sequencing system to support Caris’ evidence-based molecular profiling service. The MiSeq system will be deployed to enable simultaneous analysis of ...
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced MiSeq™, a low-cost personal sequencing system that provides individual researchers a platform with rapid turnaround time, ...
Behind the MiSeq i100 For a project like the MiSeq i100, a hardware team begins building what they call the "prototype one," or P1, instruments and consumables. Natarajan's initial goal was to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results